HOME > Research and Development
 

Research and Development

Chiesi has a passionate commitment to innovation in terms of both active ingredients and new formulations. Seventeen patent applications were filed in 2014 resulting in an exceptionally promising pipeline of potential new medicines.

 

Chiesi invests 15–20% of the total turnover of the Chiesi group every year into research and development.

 

Our Research and Development team represents a fundamental asset in our business. It comprises multi-functional business areas (focussing on pipeline projects), which include:

  • Discovery and Preclinical Research
  • Chemistry and Manufacturing Controls
  • Drug Delivery Technology
  • Clinical Development
  • Regulatory Affairs
  • Pharmacovigilance
  • Intellectual Property
  • Quality Assurance
  • Project Management and Leadership
  • Research and Development Portfolio Management. 

 

Moreover, research and development functions also support products already on the market through pharmacovigilance and regulatory activities.

 

Our traditional research and development focus is now complemented by new research areas in rare diseases, biotechnology, gene therapy and transplantation.